Embalmers Survey: 27.5% of Corpses Have White Fribrous Clots

Simian Practicalist
5 days ago
2 min read

Retired USAF Major Thomas Haviland conducted two surveys regarding those white “fribrous” blood clots embalmers reportedly keep on finding.

Credit to epidemiologist Nicolas Hulscher who conducted the one-hour interview with Haviland presenting the findings. The article and interview are on Focal Points.

The first survey is of the embalmers’ experience with 301 respondents from the US, UK, Canada and Australia. The survey was conducted in November and December 2024. Haviland makes the point that the survey does not mention COVID-19 or the vaccine to avoid “leading the witness”.

In short, although blood clots that dissolve easily are not uncommon, these white fibrous and rubbery clots have not been observed prior to the COVID-19 vaccine rollout.

Whilst 301 respondents is not a huge sample, it is not small. A few points are mentioned below:

A weighted average of 27.5% of corpses have white fribrous clots, increasing from 20% in 2023.
A weighted average of 22% of corpses have “micro-clotting” or “coffee grounds” or “dirty blood”, decreasing from 25% in 2023.
185 embalmers reported that other embalmers have observed these fribrous clots, 50 have not and, interestingly, 66 reported that this is not something talked about.

Percentage of corpses in 2024 with large whitish “fibrous” structures or clots.

The second survey is of the people with 1,425 respondents who obviously want to share their observations. Whilst this is a decent sample, the potential problem is that some of these respondents are not the patients as they are reporting people they know who have clotting issues.

Most of the respondents did not have or know of those who had clotting issues prior to the COVID-19 vaccine rollout, which corroborates the embalmers’ observations. Only 79 respondents had in 2020 with 45 unknown (presumably because they were referring to others).
1,294 had received at least one jab.
584 reported that it took at least 6 months for the clotting issues to develop, supporting the theory that these fibrous clots take 6 to 18 months to develop.